Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03354910 · ClinicalTrials.gov registry record · NA

House Calls and Peer Mentorship

A NA study, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
320
Enrollment target

NCT03354910 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 320 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03354910, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
320 participants
Enrollment target

Study Summary

Live donor kidney transplantation (LDKT) offers the most optimal survival and quality of life benefit for those with late-stage chronic kidney disease. However, minorities, especially blacks, are much less likely to receive LDKT than whites. Given the shortage of deceased donor organs, interventions expanding access to LDKT are needed, particularly for minority patients. House Calls (HC), an educational intervention developed by this study's PI has been shown to be an effective program for raising rates of live donation, especially for black patients. While the HC program has shown outstanding results, participant feedback suggested that follow-up may provide even more benefits. Previous research suggests that peer mentorship (PM) from former or current patients with ESRD may be effective in raising rates of living donation. As such, peer mentorship programs may act as an effective follow-up for HC participants. This study will examine the impact of the HC intervention combined with the peer mentorship program of the National Kidney Foundation on rates of live donor kidney transplantation.

Interventions

  • BEHAVIORAL House Call
  • BEHAVIORAL Peer Mentorship

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2018-04-30
Est. Completion 2022-12-18
Phase NA

What the Registry Record Tells You About NCT03354910

The ClinicalTrials.gov registry entry for NCT03354910 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which House Call is the first listed.

NCT03354910 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03354910 about?

NCT03354910 is a clinical study titled "House Calls and Peer Mentorship". Live donor kidney transplantation (LDKT) offers the most optimal survival and quality of life benefit for those with late-stage chronic kidney disease. However, minorities, especially blacks, are much less likely to receive LDKT than whites. Given the shortage of deceased donor organs, interventions...

What is the current status of trial NCT03354910?

This trial is currently completed. It is a NA study. The enrollment target is 320 participants. The study started on 2018-04-30. Estimated completion is 2022-12-18.

What interventions are being tested in trial NCT03354910?

The interventions under investigation include: House Call (BEHAVIORAL), Peer Mentorship (BEHAVIORAL).

Who is sponsoring clinical trial NCT03354910?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.